mometasone furoate · Intersect Ent Inc · NDA 209310
Sinuva
Earliest generic entry, as listed
24 Nov 2034
Blocked by patent: US 10232152.
Listed patents · 6 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10232152 | product, use U-2272 | 24 Nov 2034 |
| US 10406332 | product | 13 Mar 2034 |
| US 8763222 | product | 8 Feb 2032 |
| US 10357640 | use U-2272 | 3 Oct 2031 |
| US 8025635 | product, use U-2272 | 12 Jun 2027 |
| US 7544192 | use U-2272 | 29 Nov 2026 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209310 · 001 · RLD | implant, implantation | 1.35MG | 24 Nov 2034 |
Expired or delisted (1)
- US 9585681 · use U-2272 · 4 Apr 2026